Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

SHOP.COM’s Partnership With Barrington Nutritionals Proves Valuable To Successful Launch of Thymenol™, Its Exclusive Breakthrough Health Supplement

Leave a comment


SHOP.COM’s Partnership With Barrington Nutritionals Proves Crucial To Successful Launch of Thymenol™, Its Exclusive Breakthrough Health Supplement

“We are thrilled to come together with TriNutra and SHOP.COM to develop this top-selling product,” said Chris Holland, VP of Sales at Barrington Nutritionals.


GREENSBORO, N.C. (PRWEB)

SHOP.COM, Market America’s award-winning and primary global e-commerce website, is pleased with the immediate sales success following the fall launch of Thymenol™. Only available through SHOP.COM, Thymenol is a first for the health supplement industry because of its patent pending, exclusive combination of ThymoQuin™* and Pycnogenol®** — this is the only product of its kind. This synergistic combination supports cognitive health, cardiovascular health and immune health. SHOP.COM says its partnership with ingredient distributor, Barrington Nutritionals and TriNutra Ltd., a well-renowned supplier of high quality, science-based ingredients, including ThymoQuin, has played a major role in Thymenol’s initial success.±

“Thanks to our partners at Barrington Nutritionals and TriNutra, we have been able to take the incredibly powerful ingredient, ThymoQuin, a cold-pressed black seed oil standardized to 3% thymoquinone, and combine it with pine bark extract, Pycnogenol,” said Marc Ashley, President & COO of Market America Worldwide. “Thymenol exists today because of the trusted partnership we have with Barrington Nutritionals and their ability to supply ThymoQuin of the highest quality and efficacy.”

An extract of black cumin seed, ThymoQuin provides valuable antioxidant activity, aiding in cardiovascular health and healthy inflammatory response.± Black cumin has been used worldwide for centuries and multiple scientific sources have confirmed that black cumin seed oil offers beneficial effects on well-being†. Through Barrington Nutritionals and TriNutra, the manufacturer of ThymoQuin, the proprietary variety of black cumin seed in ThymoQuin is the first and only to be acquired by the cold-pressed method. Because this method does not use heat, the constituents of the oil are not altered and degraded. Black cumin seed oil is also solvent-free, preserving the effectiveness of its active ingredients.

“We are thrilled to come together with TriNutra and SHOP.COM to develop this top-selling product,” said Chris Holland, VP of Sales at Barrington Nutritionals. “ThymoQuin has proven to be a significant ingredient on its own, but when combined with Pycnogenol, it offers synergistic benefits allowing the consumer to take full advantage of the effect of the ingredients.”

Use this link to access the interactive multimedia news release now!

SHOP.COM believes that quality must be built into every product as a design requirement — hence its partnerships with elite suppliers like Barrington Nutritionals. SHOP.COM continues to look for products that will promote its customers’ well-being, placing it frequently at the forefront of the health supplement market.

*ThymoQuin™ is a trademark of TriNutra Ltd.

**Pycnogenol® is the registered trademark of Horphag Research (U.K.) Ltd. Use of this product may be protected by one or more U.S. patents and other international patents.

†National Institutes of Health (U.S.)

†Medical News Today

†Healthline

±These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

About Market America | SHOP.COM

Market America is a global product brokerage and internet marketing company that specializes in One-to-One Marketing and is the creator of the Shopping Annuity®. Its mission is to provide a robust business system for entrepreneurs while providing consumers a better way to shop. Headquartered in Greensboro, N.C. and with locations in eight countries including the U.S., Market America was begun in 1992 by Founder, Chairman and CEO JR Ridinger and has generated more than $9 billion in accumulated sales. Through the company’s primary shopping website, SHOP.COM, consumers have access to approximately 300 million products, including exclusive Market America products and thousands of top retail brands. SHOP.COM ranks 11th in Newsweek magazine’s 2020 Best Online Shops. SHOP.COM ranks No. 36 on Internet Retailer’s World’s Largest Online Marketplaces, No. 12 in the 2019 Internet Retailer Primary Merchandise Category, No. 65 in the 2018 Internet Retailer Top 500, No. 96 in the Internet Retailer Asia 500 and No. 18 in 2017’s Internet Retailer Mobile 500. The company is also a two-time winner of the Better Business Bureau’s Torch Award for Marketplace Ethics and received 2019’s Triad Business Journal’s “Fast 50” award as one of the top privately-held companies for sustained growth, driving the area’s economy — the 14th time Market America has been a “Fast 50” recipient. By combining Market America’s entrepreneurial business model with SHOP.COM’s powerful comparative shopping engine, Cashback program, Shopping Essentials, ShopBuddy® Express Pay check out, social shopping integration and countless other features, the company has become the ultimate online shopping destination. For more information: Visit marketamerica.com.

About Barrington Nutritionals

Recognized for more than 28 years for our commitment to quality, reliability and unparalleled customer service, Barrington’s diverse product portfolio serves the nutraceutical, pharmaceutical, and functional food industries. All our materials conform to or exceed the latest compendia of quality standards.

Barrington continually works to build relationships between the finest high quality ingredient producers, leading innovators and manufacturers of health and wellness products. We are honored to partner with the best ingredient manufacturers from around the world, bringing their ingredients to clients throughout North America. Our multidimensional, collaborative relationships allow us to provide new innovations, exceptional sourcing and problem-solving capabilities to our customers, guided with trust and transparency.

About TriNutra

For more information: Visit barringtonnutritionals.com

Share article on social media or email:

Industry: Healthcare

Georgia Urology announces second Lawrenceville location

Leave a comment


News Image

“By adding these respected physicians to our team, along with a second Lawrenceville location, we move forward with our mission to provide easy access to best-in-class urologists throughout Metro Atlanta and beyond,” says Jason Shelnutt, CEO of Georgia Urology.


LAWRENCEVILLE, Ga. (PRWEB)

Georgia Urology, the largest urology practice in the Southeast, is offering Lawrenceville area patients additional options under its well-respected banner. By coming together with NAUA Lawrenceville, Georgia Urology now has a second location in one of Gwinnett County’s larger cities.

Georgia Urology’s NAUA Lawrenceville practice features board-certified physicians Dr. Howard Goldberg, Dr. Douglas Nyhoff, and Dr. Jin Yeoh. The team provides state-of-the-art care across the broad spectrum of urology. This includes urologic cancers; enlarged prostate and prostate infections; kidney stones; urinary incontinence; impotence; urinary tract infections; hormone replacement therapy in men; vasectomy; and fertility evaluation in men.

“By adding these respected physicians to our team, along with a second Lawrenceville location, we move forward with our mission to provide easy access to best-in-class urologists throughout Metro Atlanta and beyond,” says Jason Shelnutt, CEO of Georgia Urology.

Patients needing the geographic convenience of highway access and a major medical facility can choose Georgia Urology’s NAUA Lawrenceville (631 Professional Drive, Suite 490, Lawrenceville). It resides in the heart of Gwinnett County near Georgia Highway 316’s Lawrenceville-Suwanee Road exit. The office is located steps away from Northside Hospital Gwinnett, a nationally recognized institution.

Georgia Urology NAUA Lawrenceville is now accepting patients. Request an appointment by calling 770-995-0424 or visiting gaurology.com/contact-us.

Interviews available upon request.

Georgia Urology is the largest urology practice in Atlanta and throughout the Southeast. Georgia Urology has more than 30 locations and six ambulatory surgery centers. The practice is comprised of more than 50 physicians, many of whom are fellowship-trained and hold advanced specialty training in oncology, robotic surgery, laparoscopy, infertility, incontinence, and pediatrics. Georgia Urology physicians use state-of-the-art diagnostic equipment and advanced treatment techniques, including robot-assisted technology and minimally invasive procedures, in order to manage all urological problems in men, women, and children. It is the practice’s mission to inform and partner with patients to develop a personalized, compassionate, and comprehensive treatment plan for all of their urological conditions.

Share article on social media or email:

Health

More Millennials are Turning to Cosmetic Procedures than Ever Before, says Beverly Hills Physicians

Leave a comment


Injectable-based procedures are grabbing the attention of younger patients.

Why are so many millennials turning to age-defying treatments? It must be the reliably positive outcomes.


BEVERLY HILLS, Calif. (PRWEB)

A December 12 article from Huffington Post states that more people between the ages of 18 and 34 are turning to fillers and injections. While using cosmetic procedures to diminish the signs of aging was once primarily associated with people in their middle years and older, more millennials are now turning to cosmetic surgery significantly earlier in life than before, according to Beverly Hills Physicians. The Southern California-based health and beauty medical group says that its team has noticed a definite upward trend in the number of younger patients visiting their offices. But why are so many millennials turning to age-defying treatments? It must be the reliably positive outcomes, says the medical group.

Beverly Hills Physicians has stated that clients who have used treatments such as Botox in their twenties and thirties have a better chance of diminishing the early signs of aging than those who wait until later in life to start treatment. The medical group adds that it offers a broad range of injectables, including facial fillers that can have dramatic impacts in terms of facial appearance. However, it is true that Botox is perhaps the most popular option even though many people are not fully aware of how it works. This injection is made up of a purified botulinum protein extracted from bacteria, says Beverly Hills Physicians. Once it is injected into the skin, it causes the muscles to remain immobile. That prohibits movement and the formation of expression lines, which helps to prevent those fine lines and wrinkles from forming.

The important thing to be aware of, notes the medical group, is that not all providers are the same and people who perform injections at certain providers may not always have a suitable medical background. Working with plastic surgeons helps to ensure that procedures are performed with maximum safety and are as effective as possible. That’s why, the group says, it’s extremely important for prospective patients to conduct research and find a skilled and reputable provider. Also, patients who are looking for more permanent outcomes often find that a combination of injectables with facelifts and other procedures can have an exceptionally powerful impact when performed by a highly experienced and skilled plastic surgeon, says Beverly Hills Physicians.

Readers who are interested in finding out more about Botox or other cosmetic procedures can contact Beverly Hills Physicians for more details regarding a very wide range of services that help patients look and feel their very best. Visit the Beverly Hills Physicians website at https://www.beverlyhillsphysicians.com/. The medical group can also be reached at 1-800-788-1416.

Share article on social media or email:

health and fitness

Weight Loss Surgery Study Showing Reduced Complications during Second Pregnancies Highlights Hidden Benefits for Many Patients, says West Medical

Leave a comment


Gastric balloons are one of a number of newer, nonsurgical bariatric procedures that are helping patients around the world.

No matter what weight loss surgery or procedure patients choose, [bariatric patients] are committing to a healthier lifestyle.


LOS ANGELES (PRWEB)

A December 6 article on Reuters reports on a new study that found a correlation between weight loss surgery and fewer complications including high blood pressure and premature birth before or during second pregnancies. The study specifically found that women who had bariatric surgery between their first and their second pregnancies were less likely to suffer adverse pregnancy outcomes the second time around. Weight loss clinic West Medical of Southern California says that the findings add to a huge and rapidly growing mountain of data supporting the health benefits of weight loss surgery.

West Medical says that there are several different forms of weight loss surgery, each with their own set of pros and cons. The clinic notes that viable options for patients looking to lose large amounts of weight include gastric sleeve, gastric bypass, endoscopic gastroplasty, and more. West Medical adds that the older surgical procedures have certain qualifiers to be met as outlined by the medical community: patients must meet the medical definition of severe obesity which involves having a high BMI (body mass index). The criteria also take weight-related health issues such as high blood pressure and type 2 diabetes into account. The clinic does note that patients who do not quite meet those requirements or who would prefer to avoid surgery are not out of options. Specifically, gastric balloon and gastroplasty are all viable nonsurgical options that have less stringent requirements.

The weight loss medical group notes that, no matter what weight loss surgery or procedure patients choose, they are committing to a healthier lifestyle that allows for more energy, decreased pain, enhanced self-esteem, and many other benefits. The clinic says that its patients who undergo successful weight loss treatments consistently find that their obesity-related ailments tend to disappear after losing significant amounts of weight.

West Medical says that obese individuals who are concerned about the cost of weight loss surgery or procedures should know that insurance may cover some or all of the relevant costs in many instances. Moreover, complications from obesity are exceedingly common and those who do not find a way to lose weight may eventually find themselves paying a very high price regardless, the clinic adds, saying that a proactive stance towards weight loss can turn out to be a very wise investment in a healthier and happier life.

For more information on West Medical and all of their services, visit their website at https://westmedical.com or call (855) 690-0565.

Share article on social media or email:

Industry: Healthcare

Vuja De Sciences Announces the Appointment of Two New Board Members

Leave a comment


“Targeting metastatic progression has been my passion for over 20 years and the team at Vuja De stands poised to rapidly translate new findings from its metastasis drug screens to effective drugs for the primary unmet need for cancer patients”, said Dr. Khanna.


HOBOKEN, N.J. (PRWEB)

Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated to developing cancer metastasis treatments that prevent cancer progression and recurrence, today announced the appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, to its Board of Directors. Rick Lampe, Co-founder and CEO of Vuja De said, “We are delighted to welcome Chand and Lee as new directors. They will be of great help in advancing our unique approach to the discovery and development of metastatic progression targeting cancer treatments in osteosarcoma and other cancers.” Dr. David Warshawsky, Vuja De’s Founder and Chairman of the Board added: “I am confident that their leadership will have a highly meaningful impact on Vuja De’s ability to translate our core anti-metastasis drug discovery platform to ground-breaking therapies against cancer progression and to our success in building a strong and leading company in the fight against cancer.”

Vuja De has been collaborating with Dr. Chand Khanna, Chief Science Officer of Ethos Veterinary Health and President of Ethos Discovery. Through this interaction VuJa De and Ethos have an innovative collaborative plan and path for metastasis-focused drug development that includes clinical trials in pet dogs with cancer (i.e. comparative oncology). “I am delighted to join the leadership at Vuja De. Targeting metastatic progression has been my passion for over 20 years and the team at Vuja De stands poised to rapidly translate new findings from its metastasis drug screens to effective drugs for the primary unmet need for cancer patients,” said Dr. Khanna.

Dr. Lee Helman stated: “I am delighted to join the Vuja De board and to work with the team to do whatever is needed to help bring treatments that prevent cancer progression and recurrence to patients with osteosarcoma and other cancers.”

“Ethos Veterinary Health is excited and highly supportive of the planned collaboration with Vuja De, beginning with Dr. Khanna joining the leadership team and soon leading to comparative oncology clinical trials that will develop effective treatments for both human and canine cancer patients,” said Ames Prentiss, CEO of Ethos Veterinary Health.

Dr. Chand Khanna

Dr. Khanna was the longtime Head of the NCI Pediatric Oncology Branch’s Tumor and Metastasis Biology Section, and the Founding Director of the Center for Cancer Research, Comparative Oncology Program. His research interests and responsibilities focused on the problem of cancer metastasis and the discovery of new options to treat patients with metastasis. Dr. Khanna has over 100 publications in the area of cancer biology and therapy. He is currently the Chief Science Officer of Ethos Veterinary Health and President of the non-profit incubator of scientific innovation, Ethos Discovery (501c.3.). In these roles Dr. Khanna seeks to improve outcomes for human and pet patients with complex medical problems through the development of novel therapeutics and diagnostics.

Dr. Lee Helman

Dr. Helman is Section Head of Basic and Translational Research within the Children’s Center for Cancer and Blood Diseases and Director of the Cancer and Blood Diseases Research Program of the Saban Research Institute of Children’s Hospital Los Angeles. He is also Professor of Pediatrics in the Keck School of Medicine of USC. Dr. Helman has been studying the biology and caring for pediatric patients with sarcomas for over thirty years. He has also trained many investigators in the field of pediatric sarcomas. One current area of active research at Children’s Hospital Los Angeles focuses on using full genomic classification of osteosarcoma tumors to improve therapy, as well as testing novel therapeutic drugs and drug combinations in patients with osteosarcoma. Dr. Helman received his medical degree from the University of Maryland School of Medicine magna cum laude in 1980 and was elected to Alpha Omega Alpha. He has served as scientific director for clinical research in the Center for Cancer Research at the NIH until 2016. He was elected to the American Society for Clinical Investigation and the American Association of Physicians and is a founding member and past president of the Connective Tissue Oncology Society. He is a past member of the Board of Governors of the Clinical Center at NIH. In addition to his many appointments with different organization, he has been appointed director of the Osteosarcoma Institute.

About Comparative Oncology

In the setting of cancer drug development, comparative oncology involves the inclusion of dogs with naturally occurring cancer in clinical trials, where novel or repurposed drugs are tested to answer questions that cannot be answered in conventional animal models of cancer or human clinical trials.

About Osteosarcoma

Osteosarcoma is an aggressive cancer of the bone in dogs and human patients and is the most common type of bone cancer in children and teens. Despite successful control of the primary tumor and follow-up chemotherapy, metastasis continues to be the most common cause of mortality for both species. The last 30 years have brought little improvement in survival outcomes for children with osteosarcoma, despite intensification of therapy. Due to lack of improved outcomes, new approaches to therapy are highly needed. Furthermore, if targeted therapeutics are found to prevent metastasis in this human cancer, a strong biological rationale would exist for the evaluation of such a therapy in other human cancers.

About Ethos Veterinary Health

Ethos is a veterinary health company with hospitals across the U.S. providing advanced medical care for pets. Our approach includes a focus on transformative science, continuous learning, growth for team members, and the development of collaborative relationships. For more information, visit ethosvet.com.

About Ethos Discovery

Ethos Discovery is a 501(c)3 non-profit incubator of scientific innovation that seeks to improve health outcomes in pets and humans with complex medical problems, including cancer. For more information, please visit ethosdiscovery.org

About Vuja De Sciences

Vuja De is a biotechnology startup dedicated to developing cancer metastasis treatments that prevent cancer progression and recurrence. Our initial focus is osteosarcoma. We utilize leading laboratory technologies for metastatic preclinical endpoints in combination with Comparative Oncology to de risk and inform product development and maximize likelihood for successful human oncology clinical trials. We are testing repurposed drugs that have previously been in human clinical trials, as well as novel preclinical drugs. For more information, please visit vujade-life.com.

Share article on social media or email:

Health

German Pharma Company Boehringer Ingelheim licenses AI/NLP Platform from Kairntech

Leave a comment


The Pharma sector is a very knowledge-intensive business – automatic support for the analysis of document content by appropriate AI is dearly needed.

“Powerful AI and NLP (natural language processing) software is vital to accomplish knowledge discovery in an efficient and fast manner for our scientists.” Dr. Karlheinz Spenny, Boehringer Ingelheim


BIBERACH/HEIDELBERG, Germany (PRWEB)

The German pharma company Boehringer-Ingelheim (BI) and AI software startup Kairntech from Grenoble in France have announced their cooperation on tasks around the analysis of text-based information. The foundation of the cooperation is the licensing of Kairntech’s software platform Sherpa by Boehringer-Ingelheim.

“Drug Discovery is a knowledge–driven business,” explains Dr. Karlheinz Spenny, Head of the Scientific Information Center at Boehringer´s R&D site in Germany. “Much of what we know today resides as unstructured text in scientific publications, patents, conference abstracts or on websites. Making sense of (hidden) relations e.g. between genes and cellular targets. Such knowledge is crucial for discovery research scientists. Powerful AI and NLP (natural language processing) software is vital to accomplish knowledge discovery in an efficient and fast manner for our scientists.”

Boehringer has therefore decided to license the Kairntech AI platform Sherpa. Kairntech and BI have assessed the performance of the software on a number of tasks such as document categorization and the recognition of domain specific entities in explorative projects with Boehringer-specific requirements. A key aspect of the platform is the fact that while powerful machine learning methods are implemented under the hood, the handling of the platform is kept simple and intuitive such that domain experts can train and tune new document processing models without having to engage in complex rule writing or programming.

“We are living in exciting times in the area of NLP and AI,” says Stefan Geißler, Cofounder at Kairntech. “The field is progressing with relentless speed and use cases that would have required extensive manual efforts until recently, today can be addressed with appropriate methods such as Deep Learning and others.”

Details of the deal have not been disclosed.

About Boehringer Ingelheim

Boehringer Ingelheim with its three business areas human pharmaceuticals, animal health and biopharmaceuticals is one of the top 20 innovative Pharma companies worldwide and family-owned since 1885. Some 50,000 employees create value on diseases for which no satisfactory treatment option exists to date. The company concentrates on developing innovative therapies that can extend patients’ lives. More information about Boehringer Ingelheim can be found on http://www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

About Kairntech

Kairntech is a French AI and NLP startup from Grenoble, created in 2018. The team has a long joint history of developing and applying AI software to industry challenges. More on Kairntech at http://www.kairntech.com, email: info@kairntech.com

Share article on social media or email:

health and fitness

NEW Environmental-Facing Skin Care Line is a Game Changer

Leave a comment


Amethyst Skincare


LOS ANGELES (PRWEB)

Amethyst Skincare makes its debut today as the FIRST skin care line created for the sole purpose of protecting the skin from the declining environment. The brand launches with three essential products: Daily Nutrition Facial Oil, Nightly AOX Micro Peel and Daily Airborne Pollution and Smog Neutralizer. The brainchild of beauty veteran, Nicole Simpson, Amethyst was formulated to nourish and protect the skin from environmental stressors such as pollution, UV exposure, ground-level ozone, and stress.

Just like the Amethyst stone is known for its healing properties, Amethyst Beauty uses potent ingredients and an innovative delivery system to heal the skin by restoring the skin barrier while also arming it with the basic needs to neutralize all the environment’s free radicals. The paraben, gluten and cruelty-free products designed to act as a supplement to everyday skincare, includes:


  •     Daily Nutrition Facial Oil ($75): Formulated with a proprietary blend of jasmine, neroli, and marula oils helps manage skin discoloration and protect against pollution-related aging, hormonal aging, and environmental stress. Infused with vitamin E to protect the skin against pollution, ground-level ozone and UV, as well as Omega 6 and 9 fatty acids.

  •     Daily Airborne Pollution and Smog Neutralizer ($34): This nutrient-dense hydrating protective spray combines vitamin C and niacinamide with vitamins B5, E, A, and a proprietary pollution-neutralizing botanical complex of super antioxidants. They work synergistically to neutralize the free radicals created from the many different types of pollutants we encounter on our skin each day – including ground-level ozone, superoxide, nitrous-oxide and others.

  •     Nightly AOX Micro peel ($85): This unprecedented combination of glycolic acid, salicylic acid, and retinol in one formula boosts cell turnover and collagen production while r-lipoic acid re-energizes cells from the inside out. Discolorations are lightened, wrinkles are smoothed, radiance is boosted, and free radicals removed from lack of sleep and environmental exposure. It also helps prepare skin for enhanced penetration of other skincare products and active ingredients.


Amethyst is committed to being environmentally conscious in its formulation, packaging and production. To reduce stress on environmental resources most of the products are in glass containers and are created with reduced water use. While more than 85 percent of beauty products are not recyclable, Amethyst products are 100 percent recyclable and the brand will provide customers with the opportunity to mail back empty bottles to ensure they are properly disposed.

“The beauty industry is a big contributor to that [pollution] – sourcing to countries like China & India because of the cost,” says Amethyst creator, Nicole Simpson. “We need someone to lead the charge and get real with consumers.”

In addition to the brand’s recycling program Amethyst is committed to donating 5 percent of every purchase to 4ocean – an amazing non-profit that works hard every day to remove plastic from our oceans.

Amethyst Skincare is available at SkinByAmethyst.com.

About the Founder:

Founder and creator of Amethyst Skincare, Nicole Simpson, is a biochemist, medical aesthetician, educator and 15-year beauty veteran. With a deep passion for beauty, Nicole has been formulating skin care since she was a teenager. As the former Head of Education for Glytone, and the AVP of Global Education and Business Development at SkinCeuticals/L’Oreal, Nicole has a deep understanding of the physiology of the skin and has trained some of the world’s leading dermatologists. When it comes to formulating skin care, she went back to her roots to develop a formula that helps the skin heal itself from environmental toxins and stressors.

###

Share article on social media or email:

Industry: Healthcare

Altruista Health Integrates InterQual Connect™ Solution to Automate Pre-authorizations in GuidingCare

Leave a comment


News Image

As an Alliance Partner, Altruista can support its health plan members in strengthening payer-provider relationships — Nilo Mehrabian, Vice President of Product Management, Decision Support, Change Healthcare


RESTON, Va. (PRWEB)

Altruista Health, an innovative provider of care management technology solutions for health plans and provider organizations, today said it is joining forces with Change Healthcare as a Validated InterQual Alliance Partner to deliver dramatically streamlined utilization management (UM) for Altruista customers who rely on the GuidingCare® technology platform.

“We are pleased to support Altruista Health in offering its customers automated pre-authorizations within the InterQual Connect medical review service. This integration allows health plans to approve routine requests in real time and free up UM staff to focus on requests that require further medical review,” said Nilo Mehrabian, Vice President of Product Management, Decision Support, Change Healthcare. “As an Alliance Partner, Altruista can support its health plan customers in strengthening payer-provider relationships.”

GuidingCare has integrated the InterQual Connect medical review service into its UM module and connected it with GuidingCare’s module for provider access, driving easier, faster and more transparent prior authorizations in support of quality care. The exception-based design streamlines administrative workflow to reduce manual processes and redundant medical reviews. This integration will work with any version of GuidingCare.

“We have multiple Altruista customers already leveraging this capability within their current GuidingCare workflows,” said Craig Wigginton, Altruista Health Chief Technology Officer. “Health plans considering an upgrade to the InterQual Connect medical review service can rest assured that this integration has been tested and is in place.”

InterQual Connect is a flexible SaaS solution, integrated into payer and provider health information systems. It pairs with InterQual® Criteria, available as a web service, with proven and secure connectivity to fill the gap in current care management systems. This mutually beneficial connectivity and function supports value-based care and more resources available to caring for plan members.

About Altruista Health

Altruista Health delivers care management and population health management solutions that support value-based and person-centered care models. Our GuidingCare® technology platform integrates care management, care coordination and quality improvement programs through a suite of sophisticated yet easy-to-use web applications. GuidingCare is the largest and most widely adopted platform of its kind in the United States. Founded in 2007 and headquartered in the Washington, D.C. area, Altruista Health has grown into a recognized industry leader, and was named twice as one of the Top Population Health Management Companies to Know by Becker’s Healthcare. Health plans and healthcare providers use GuidingCare to transform their processes, reduce avoidable expenses and improve patient health outcomes. For more information, visit http://www.altruistahealth.com.

Share article on social media or email:

Health

Mark Ziegler joins Life Science Law Firm, Boesen and Snow

Leave a comment



SCOTTSDALE, Ariz. (PRWEB)

Boesen and Snow Law is pleased to announce Mark Ziegler has joined the firm as Director of Pharmacy Services effective October 7, 2019 to assist in expanding the pharmacy specific services offered by the firm.

Mark earned his Doctor of Pharmacy from Duquesne University in 2007 and his MBA from Case Western Reserve University in 2010. Mark has over 10 years of experience as a pharmacist and over 15 years combined experience working in retail pharmacies and at a major PBM. Mark previously came from the PBM sector in which he led the PBM’s Investigative Audit Team responsible for conducting in depth audits on network pharmacies, primarily targeting potential Fraud, Waste, and Abuse. Mark’s expertise in pharmacy audit includes a deep understanding of the processes utilized by PBM’s to determine audit findings, providing a timely and effective audit response, proactive approaches to maintaining the PBM relationship, and knowledge of PBM Provider Agreements.

We look forward to expanding our services to Pharmacy related clients while providing a level of PBM expertise that only Boesen and Snow Law can offer.

Education

  • Case Western Reserve University, Cleveland, Ohio – M.B.A.- 2010

  • Duquesne University, Pittsburgh, Pennsylvania – Pharm.D. – 2007

Share article on social media or email:

Health

G-CON Manufacturing Announces the Unveiling of a New 25,000 Sq. ft. Facility for POD Manufacturing

Leave a comment


POD manufacturing site for prefabricated mobile cleanrooms

G-CON Manufacturing Phase 4

This facility allows us to grow our capacity from 170 to 200 PODs per year, a 15% increase.


COLLEGE STATION, Texas (PRWEB)

G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, today unveiled another facility expansion, adding to the company’s 200,000 sq. ft. manufacturing site in College Station, TX. The new facility, opening January 2020, consists of 25,000 sq. ft. of manufacturing space dedicated to POD architectural, mechanical, electrical and automation fit out.

“This facility allows us to grow our capacity from 170 to 200 PODs per year, a 15% increase,” said Blake Williams, Vice President of Operations at G-CON Manufacturing. “With the orders that we have received and the ever-expanding pipeline of new opportunities, we are continuing to invest in our facilities and elsewhere so that the POD value proposition can be fully realized. The facility will be equipped with a chilled water system and will be hot water capable. Electrical and waste systems will also be in place to support Factory Acceptance Tests provided with every project.

This development completes Phase 4 of G-CON’s growth at its manufacturing site in Texas. G-CON recently announced another 25,000 sq. ft. facility expansion for superstructures, doubling the company’s superstructure capacity.

About G-CON Manufacturing

G-CON Manufacturing designs, builds and installs prefabricated cleanrooms. G-CON’s POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD cleanrooms surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing once the production process reaches its lifecycle end. For more information, please visit G-CON’s website at http://www.gconbio.com.

Share article on social media or email: